Feedback / Questions
Glymera (PB1023) - PhaseBio Pharma
PhaseBio Pharmaceuticals: Jefferies Global Healthcare Conference
(Phase Bio)
-
Jul 22, 2013 -
Anticipated patent expiry in US for GLP-1 receptor agonist fusions with ELP for diabetes on Jun 29, 2029
Anticipated patent expiry
•
Diabetes
http://phasebio.com/files/PhaseBio-Noncon-Jefferies-Presentation-2013.pdf
Jul 22, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.